BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen X, Duan N, Zhang C, Zhang W. Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies. J Cancer 2016;7:314-23. [PMID: 26918045 DOI: 10.7150/jca.13332] [Cited by in Crossref: 137] [Cited by in F6Publishing: 137] [Article Influence: 27.4] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Lu W, Yang J, Edwards M, Jiang S. Survivin as a biological biomarker for diagnosis and therapy. Expert Opin Biol Ther 2021;:1-13. [PMID: 33877952 DOI: 10.1080/14712598.2021.1918672] [Reference Citation Analysis]
2 Nasrollahzadeh A, Momeny M, Fasehee H, Yaghmaie M, Bashash D, Hassani S, Mousavi SA, Ghaffari SH. Anti-proliferative activity of disulfiram through regulation of the AKT-FOXO axis: A proteomic study of molecular targets. Biochim Biophys Acta Mol Cell Res 2021;1868:119087. [PMID: 34182011 DOI: 10.1016/j.bbamcr.2021.119087] [Reference Citation Analysis]
3 Dong X, Wang L, Han Z, Zhou L, Shan L, Ding Y, Xu W, Li J, Su Y, Cai R, Xiong G, Diao D, Dai M, Jia C, Zheng H. Different functions of DEPTOR in modulating sensitivity to chemotherapy for esophageal squamous cell carcinoma. Exp Cell Res 2017;353:35-45. [PMID: 28267437 DOI: 10.1016/j.yexcr.2017.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
4 Or CR, Huang CW, Chang CC, Lai YC, Chen YJ, Chang CC. Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling. Int J Mol Sci 2020;21:E1773. [PMID: 32150830 DOI: 10.3390/ijms21051773] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
5 Roy NK, Monisha J, Padmavathi G, Lalhruaitluanga H, Kumar NS, Singh AK, Bordoloi D, Baruah MN, Ahmed GN, Longkumar I, Arfuso F, Kumar AP, Kunnumakkara AB. Isoform-Specific Role of Akt in Oral Squamous Cell Carcinoma. Biomolecules 2019;9:E253. [PMID: 31252679 DOI: 10.3390/biom9070253] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
6 Sales L, de Sousa GR, Ferreira-Silva GÁ, Castro-Gamero AM, Ionta M, de Oliveira JC. YM155 induces apoptosis in p53-deficient T-acute lymphoblastic leukemia cells independent of survivin inhibition. Anticancer Drugs 2017;28:298-306. [PMID: 27930382 DOI: 10.1097/CAD.0000000000000462] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ghazi N, Khorasanchi M. Markers associated with malignant transformation of oral lichen planus: A review article. Arch Oral Biol 2021;127:105158. [PMID: 34022545 DOI: 10.1016/j.archoralbio.2021.105158] [Reference Citation Analysis]
8 Ercan A, Çelebier M, Oncul S, Varan G, Kocak E, Benito JM, Bilensoy E. Polycationic cyclodextrin nanoparticles induce apoptosis and affect antitumoral activity in HepG2 cell line: An evaluation at the molecular level. Int J Pharm 2021;598:120379. [PMID: 33592288 DOI: 10.1016/j.ijpharm.2021.120379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Umeda S, Kanda M, Miwa T, Tanaka H, Tanaka C, Kobayashi D, Hayashi M, Yamada S, Nakayama G, Koike M, Kodera Y. Fraser extracellular matrix complex subunit 1 promotes liver metastasis of gastric cancer. Int J Cancer 2020;146:2865-76. [PMID: 31597194 DOI: 10.1002/ijc.32705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
10 Hua X, Li G, Liu Z, Niu Z. LINK-A lncRNA participates in the pathogenesis of glioma by interacting with survivin. Exp Ther Med 2019;18:1581-6. [PMID: 31410112 DOI: 10.3892/etm.2019.7716] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Chen X, Chen XG, Hu X, Song T, Ou X, Zhang C, Zhang W, Zhang C. MiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma Cells. J Cancer 2016;7:1057-65. [PMID: 27326248 DOI: 10.7150/jca.15061] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
12 Chen WT, Hsu FT, Liu YC, Chen CH, Hsu LC, Lin SS. Fluoxetine Induces Apoptosis through Extrinsic/Intrinsic Pathways and Inhibits ERK/NF-κB-Modulated Anti-Apoptotic and Invasive Potential in Hepatocellular Carcinoma Cells In Vitro. Int J Mol Sci 2019;20:E757. [PMID: 30754643 DOI: 10.3390/ijms20030757] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
13 Heendeniya SN, Keerthirathna LR, Manawadu CK, Dissanayake IH, Ali R, Mashhour A, Alzahrani H, Godakumbura P, Boudjelal M, Peiris DC. Therapeutic Efficacy of Nyctanthes arbor-tristis Flowers to Inhibit Proliferation of Acute and Chronic Primary Human Leukemia Cells, with Adipocyte Differentiation and in Silico Analysis of Interactions between Survivin Protein and Selected Secondary Metabolites. Biomolecules 2020;10:E165. [PMID: 31973079 DOI: 10.3390/biom10020165] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
14 Hakim SA, Abou Gabal HH. Diagnostic Utility of BAP1, EZH2 and Survivin in Differentiating Pleural Epithelioid Mesothelioma and Reactive Mesothelial Hyperplasia: Immunohistochemical Study. Pathol Oncol Res 2021;27:600073. [PMID: 34257556 DOI: 10.3389/pore.2021.600073] [Reference Citation Analysis]
15 Waligórska-Stachura J, Sawicka-Gutaj N, Zabel M, Andrusiewicz M, Gut P, Czarnywojtek A, Ruchała M. Survivin DEx3 as a biomarker of thyroid cancers: A study at the mRNA and protein level. Oncol Lett 2017;13:2437-41. [PMID: 28454416 DOI: 10.3892/ol.2017.5713] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
16 Hamy AS, Bieche I, Lehmann-Che J, Scott V, Bertheau P, Guinebretière JM, Matthieu MC, Sigal-Zafrani B, Tembo O, Marty M, Asselain B, Spyratos F, de Cremoux P. BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy. Breast Cancer Res Treat 2016;159:499-511. [PMID: 27592112 DOI: 10.1007/s10549-016-3961-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
17 Pluthero FG, Kahr WHA. Balancing the yin and yang of SINE. Blood 2017;130:1077-8. [PMID: 28860324 DOI: 10.1182/blood-2017-07-793398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Turrini E, Sestili P, Fimognari C. Overview of the Anticancer Potential of the "King of Spices" Piper nigrum and Its Main Constituent Piperine. Toxins (Basel) 2020;12:E747. [PMID: 33256185 DOI: 10.3390/toxins12120747] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Lins RR, Oshima CT, Oliveira LA, Silva MS, Mader AM, Waisberg J. EXPRESSION OF E-CADHERIN AND WNT PATHWAY PROTEINS BETACATENIN, APC, TCF-4 AND SURVIVIN IN GASTRIC ADENOCARCINOMA: CLINICAL AND PATHOLOGICAL IMPLICATION. Arq Bras Cir Dig 2016;29:227-31. [PMID: 28076475 DOI: 10.1590/0102-6720201600040004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
20 Kang HS, Kwon HY, Kim IK, Ban WH, Kim SW, Kang HH, Yeo CD, Lee SH. Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer. Sci Rep 2020;10:1854. [PMID: 32024881 DOI: 10.1038/s41598-020-58906-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
21 Wang YL, Shao X, Wang F, Zeng L, Hu L, Cui SQ, Hou G, Huang DN. Intron-specific shRNA-mediated downregulation of survivin and promotion of apoptosis in HeLa cells. Oncol Lett 2017;14:5927-33. [PMID: 29113228 DOI: 10.3892/ol.2017.6996] [Reference Citation Analysis]
22 Pullamsetti SS, Savai R, Seeger W, Goncharova EA. Translational Advances in the Field of Pulmonary Hypertension. From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs. Am J Respir Crit Care Med 2017;195:425-37. [PMID: 27627135 DOI: 10.1164/rccm.201606-1226PP] [Cited by in Crossref: 78] [Cited by in F6Publishing: 55] [Article Influence: 19.5] [Reference Citation Analysis]
23 Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ. Gemigliptin, a novel dipeptidyl peptidase-IV inhibitor, exerts a synergistic cytotoxicity with the histone deacetylase inhibitor PXD101 in thyroid carcinoma cells. J Endocrinol Invest 2018;41:677-89. [PMID: 29147952 DOI: 10.1007/s40618-017-0792-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
24 Marioni G, Ottaviano G, Marchese-ragona R, Fasanaro E, Tealdo G, Zanotti C, Randon B, Giacomelli L, Stellini E, Blandamura S. Nuclear survivin expression correlates with endoglin-assessed microvascularisation in laryngeal carcinoma. J Clin Pathol 2017;70:1033-7. [DOI: 10.1136/jclinpath-2016-204230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Yuan B, Xu K, Shimada R, Li J, Hayashi H, Okazaki M, Takagi N. Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines. Front Oncol 2021;11:628914. [PMID: 33796463 DOI: 10.3389/fonc.2021.628914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Voges Y, Michaelis M, Rothweiler F, Schaller T, Schneider C, Politt K, Mernberger M, Nist A, Stiewe T, Wass MN, Rödel F, Cinatl J. Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance. Cell Death Dis 2016;7:e2410. [PMID: 27735941 DOI: 10.1038/cddis.2016.257] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
27 Danielpour D, Gao Z, Zmina PM, Shankar E, Shultes BC, Jobava R, Welford SM, Hatzoglou M. Early Cellular Responses of Prostate Carcinoma Cells to Sepantronium Bromide (YM155) Involve Suppression of mTORC1 by AMPK. Sci Rep 2019;9:11541. [PMID: 31395901 DOI: 10.1038/s41598-019-47573-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
28 Nie JJ, Liu Y, Qi Y, Zhang N, Yu B, Chen DF, Yang M, Xu FJ. Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma. J Control Release 2021;333:362-73. [PMID: 33785418 DOI: 10.1016/j.jconrel.2021.03.030] [Reference Citation Analysis]
29 Hu F, Pan D, Zheng W, Yan T, He X, Ren F, Lu Y, Ma X. Elucidating respective functions of two domains BIR and C-helix of human IAP survivin for precise targeted regulating mitotic cycle, apoptosis and autophagy of cancer cells. Oncotarget 2017;8:113687-700. [PMID: 29371939 DOI: 10.18632/oncotarget.22823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
30 Gleichenhagen J, Arndt C, Casjens S, Meinig C, Gerullis H, Raiko I, Brüning T, Ecke T, Johnen G. Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine. Int J Mol Sci 2018;19:E226. [PMID: 29324722 DOI: 10.3390/ijms19010226] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
31 Hao Q, Tang H. Interferon-γ and Smac mimetics synergize to induce apoptosis of lung cancer cells in a TNFα-independent manner. Cancer Cell Int 2018;18:84. [PMID: 29946223 DOI: 10.1186/s12935-018-0579-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 de Graaff MA, Malu S, Guardiola I, Kruisselbrink AB, de Jong Y, Corver WE, Gelderblom H, Hwu P, Nielsen TO, Lazar AJ, Somaiah N, Bovée JVMG. High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth. Transl Oncol 2017;10:546-54. [PMID: 28654818 DOI: 10.1016/j.tranon.2017.05.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
33 Dufour F, Silina L, Neyret-Kahn H, Moreno-Vega A, Krucker C, Karboul N, Dorland-Galliot M, Maillé P, Chapeaublanc E, Allory Y, Stransky N, Haegel H, Menguy T, Duong V, Radvanyi F, Bernard-Pierrot I. TYRO3 as a molecular target for growth inhibition and apoptosis induction in bladder cancer. Br J Cancer 2019;120:555-64. [PMID: 30765874 DOI: 10.1038/s41416-019-0397-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
34 Kang K, Xie F, Wu Y, Wang Z, Wang L, Long J, Lian X, Zhang F. Comprehensive exploration of tumor mutational burden and immune infiltration in diffuse glioma. Int Immunopharmacol 2021;96:107610. [PMID: 33848908 DOI: 10.1016/j.intimp.2021.107610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Saulino DM, Younes PS, Bailey JM, Younes M. CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity. Oncotarget 2018;9:21289-95. [PMID: 29765539 DOI: 10.18632/oncotarget.25088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
36 Gil-Kulik P, Krzyżanowski A, Dudzińska E, Karwat J, Chomik P, Świstowska M, Kondracka A, Kwaśniewska A, Cioch M, Jojczuk M, Nogalski A, Kocki J. Potential Involvement of BIRC5 in Maintaining Pluripotency and Cell Differentiation of Human Stem Cells. Oxid Med Cell Longev 2019;2019:8727925. [PMID: 30774747 DOI: 10.1155/2019/8727925] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
37 Chain MO, Paiva CAM, Maciel IO, Neto AN, Castro VF, Oliveira CP, Mendonça BDS, Nestal de Moraes G, Reis SAD, Carvalho MA, De-Melo LDB. Galectin-3 mediates survival and apoptosis pathways during Trypanosoma cruzi-host cell interplay. Exp Parasitol 2020;216:107932. [PMID: 32535113 DOI: 10.1016/j.exppara.2020.107932] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Kushwaha PP, Vardhan PS, Kapewangolo P, Shuaib M, Prajapati SK, Singh AK, Kumar S. Bulbine frutescens phytochemical inhibits notch signaling pathway and induces apoptosis in triple negative and luminal breast cancer cells. Life Sci 2019;234:116783. [PMID: 31442552 DOI: 10.1016/j.lfs.2019.116783] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
39 Chen Y, Bieerkehazhi S, Li X, Ma L, Yibulayin W, Ran J. Survivin Regulates Bad Gene Expression by Binding to Its Promoter and Modulates Cell Cycle and Apoptosis in Esophageal Carcinoma Cell. J Oncol 2021;2021:1384289. [PMID: 33488710 DOI: 10.1155/2021/1384289] [Reference Citation Analysis]
40 Miyamoto R, Tani H, Ikeda T, Saima H, Tamura K, Bonkobara M. Commitment toward cell death by activation of autophagy with survivin inhibitor YM155 in two canine squamous cell carcinoma cell lines with high expression of survivin. Res Vet Sci 2021;135:412-5. [PMID: 33160684 DOI: 10.1016/j.rvsc.2020.10.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Wang DY, Li N, Cui YL. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving. Cancer Res Treat 2020;52:798-814. [PMID: 32124583 DOI: 10.4143/crt.2019.498] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 12.0] [Reference Citation Analysis]
42 Stavropoulos A, Varras M, Vasilakaki T, Varra VK, Varra FN, Tsavari A, Nonni A, Kavantzas N, Lazaris AC. Expression of anti-apoptotic protein survivin in human endometrial carcinoma: Clinical and pathological associations as a separate factor and in combination with concomitant PTEN and p53 expression. Oncol Lett 2020;20:1033-54. [PMID: 32724342 DOI: 10.3892/ol.2020.11690] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
43 Chen B, Wang J, Dai D, Zhou Q, Guo X, Tian Z, Huang X, Yang L, Tang H, Xie X. AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer. J Exp Clin Cancer Res 2017;36:65. [PMID: 28494797 DOI: 10.1186/s13046-017-0522-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
44 Jia Y, Hu R, Li P, Zheng Y, Wang Y, Ma X. DEC1 is required for anti-apoptotic activity of gastric cancer cells under hypoxia by promoting Survivin expression. Gastric Cancer 2018;21:632-42. [PMID: 29204860 DOI: 10.1007/s10120-017-0780-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
45 Kiss T, Jámbor K, Koroknai V, Szász I, Bárdos H, Mokánszki A, Ádány R, Balázs M. Silencing Osteopontin Expression Inhibits Proliferation, Invasion and Induce Altered Protein Expression in Melanoma Cells. Pathol Oncol Res 2021;27:581395. [PMID: 34257527 DOI: 10.3389/pore.2021.581395] [Reference Citation Analysis]
46 Hunsu VO, Facey COB, Fields JZ, Boman BM. Retinoids as Chemo-Preventive and Molecular-Targeted Anti-Cancer Therapies. Int J Mol Sci 2021;22:7731. [PMID: 34299349 DOI: 10.3390/ijms22147731] [Reference Citation Analysis]
47 Garrido MP, Salvatierra R, Valenzuela-Valderrama M, Vallejos C, Bruneau N, Hernández A, Vega M, Selman A, Quest AFG, Romero C. Metformin Reduces NGF-Induced Tumour Promoter Effects in Epithelial Ovarian Cancer Cells. Pharmaceuticals (Basel) 2020;13:E315. [PMID: 33081077 DOI: 10.3390/ph13100315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Vivarelli S, Falzone L, Ligresti G, Candido S, Garozzo A, Magro GG, Bonavida B, Libra M. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets. Int J Mol Sci 2020;21:E6446. [PMID: 32899428 DOI: 10.3390/ijms21176446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Benaiges E, Ceperuelo-Mallafré V, Madeira A, Bosch R, Núñez-Roa C, Ejarque M, Maymó-Masip E, Huber-Ruano I, Lejeune M, Vendrell J, Fernández-Veledo S. Survivin drives tumor-associated macrophage reprogramming: a novel mechanism with potential impact for obesity. Cell Oncol (Dordr) 2021;44:777-92. [PMID: 33710603 DOI: 10.1007/s13402-021-00597-x] [Reference Citation Analysis]
50 Fuchigami T, Ishikawa N, Nozaki I, Miyanari Y, Yoshida S, Yamauchi M, Soejima A, Haratake M, Nakayama M. Discovery of inner centromere protein-derived small peptides for cancer imaging and treatment targeting survivin. Cancer Sci 2020;111:1357-66. [PMID: 31991041 DOI: 10.1111/cas.14330] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Liang J, Zhao W, Tong P, Li P, Zhao Y, Li H, Liang J. Comprehensive molecular characterization of inhibitors of apoptosis proteins (IAPs) for therapeutic targeting in cancer. BMC Med Genomics 2020;13:7. [PMID: 31964418 DOI: 10.1186/s12920-020-0661-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
52 Játiva P, Ceña V. Use of nanoparticles for glioblastoma treatment: a new approach. Nanomedicine 2017;12:2533-54. [DOI: 10.2217/nnm-2017-0223] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
53 Jo G, Kwon MJ, Kim JN, Kim BJ. Radix Sophorae Flavescentis induces apoptosis through by Caspase, MAPK Activation and ROS Signaling Pathways in 5637 Human Bladder Cancer Cells. Int J Med Sci 2020;17:1474-81. [PMID: 32669949 DOI: 10.7150/ijms.45831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
54 Fiedler M, Renner P, Schubert J, Weber F, Hartmann A, Iro H, Vielsmeier V, Bohr C, Gerken M, Reichert TE, Ettl T. Predictive value of FHIT, p27, and pERK1/ERK2 in salivary gland carcinomas: a retrospective study. Clin Oral Invest 2019;23:3801-9. [DOI: 10.1007/s00784-019-02809-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Shafran Y, Zurgil N, Ravid-Hermesh O, Sobolev M, Afrimzon E, Hakuk Y, Shainberg A, Deutsch M. Nitric oxide is cytoprotective to breast cancer spheroids vulnerable to estrogen-induced apoptosis. Oncotarget 2017;8:108890-911. [PMID: 29312577 DOI: 10.18632/oncotarget.21610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
56 Li J, Han Y, Zhou D, Zhou Y, Ye M, Wang H, Du Z. Downregulation of Survivin Gene Expression Affects Ionizing Radiation Resistance of Human T98 Glioma Cells. Cell Mol Neurobiol 2018;38:861-8. [PMID: 29098505 DOI: 10.1007/s10571-017-0560-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
57 Shakeel E, Akhtar S, Khan MKA, Lohani M, Arif JM, Siddiqui MH. Molecular docking analysis of aplysin analogs targeting survivin protein. Bioinformation 2017;13:293-300. [PMID: 29081608 DOI: 10.6026/97320630013293] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
58 Wanandi SI, Limanto A, Yunita E, Syahrani RA, Louisa M, Wibowo AE, Arumsari S. In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells. PLoS One 2020;15:e0240020. [PMID: 33211707 DOI: 10.1371/journal.pone.0240020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
59 Huang YH, Yeh CT. Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells. Cells 2019;9:E23. [PMID: 31861751 DOI: 10.3390/cells9010023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
60 Ge L, Yang Y, Sun Y, Xu W, Lu D, Su B. P73 G4C14-to-A4T14 polymorphism is associated with survival in advanced non-small cell lung cancer patients. Thorac Cancer 2017;8:63-72. [PMID: 28134496 DOI: 10.1111/1759-7714.12397] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
61 Badana AK, Chintala M, Gavara MM, Naik S, Kumari S, Kappala VR, Iska BR, Malla RR. Lipid rafts disruption induces apoptosis by attenuating expression of LRP6 and survivin in triple negative breast cancer. Biomed Pharmacother 2018;97:359-68. [PMID: 29091885 DOI: 10.1016/j.biopha.2017.10.045] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
62 Yu Y, Shang R, Chen Y, Li J, Liang Z, Hu J, Liu K, Chen C. Tumor suppressive ZBTB4 inhibits cell growth by regulating cell cycle progression and apoptosis in Ewing sarcoma. Biomedicine & Pharmacotherapy 2018;100:108-15. [DOI: 10.1016/j.biopha.2018.01.132] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
63 Akbar Samadani A, Keymoradzdeh A, Shams S, Soleymanpour A, Elham Norollahi S, Vahidi S, Rashidy-Pour A, Ashraf A, Mirzajani E, Khanaki K, Rahbar Taramsari M, Samimian S, Najafzadeh A. Mechanisms of cancer stem cell therapy. Clin Chim Acta. 2020;510:581-592. [PMID: 32791136 DOI: 10.1016/j.cca.2020.08.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
64 Marioni G, Brescia G, Nicolè L, Marchese-ragona R, Barion U, Giacomelli L, Marino F, Martini A, Ottaviano G. Survivin and cortactin expression in sinonasal schneiderian (inverted) papilloma and associated carcinoma. Am J Rhinol�Allergy 2018;32:78-81. [DOI: 10.1177/1945892418762644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
65 Inder S, O'Rourke S, McDermott N, Manecksha R, Finn S, Lynch T, Marignol L. The Notch-3 receptor: A molecular switch to tumorigenesis? Cancer Treat Rev 2017;60:69-76. [PMID: 28889086 DOI: 10.1016/j.ctrv.2017.08.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
66 Rangel N, Villegas VE, Rondón-Lagos M. Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines. Breast Cancer (Dove Med Press) 2017;9:537-50. [PMID: 29033607 DOI: 10.2147/BCTT.S146247] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
67 Cucci MA, Compagnone A, Daga M, Grattarola M, Ullio C, Roetto A, Palmieri A, Rosa AC, Argenziano M, Cavalli R, Simile MM, Pascale RM, Dianzani C, Barrera G, Pizzimenti S. Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells. Free Radical Biology and Medicine 2019;141:205-19. [DOI: 10.1016/j.freeradbiomed.2019.06.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
68 Finlay D, Teriete P, Vamos M, Cosford NDP, Vuori K. Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins. F1000Res 2017;6:587. [PMID: 28529715 DOI: 10.12688/f1000research.10625.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
69 Stobiecka M, Ratajczak K, Jakiela S. Toward early cancer detection: Focus on biosensing systems and biosensors for an anti-apoptotic protein survivin and survivin mRNA. Biosens Bioelectron 2019;137:58-71. [PMID: 31078841 DOI: 10.1016/j.bios.2019.04.060] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 16.0] [Reference Citation Analysis]
70 Yu P, Li AX, Chen XS, Tian M, Wang HY, Wang XL, Zhang Y, Wang KS, Cheng Y. PKM2-c-Myc-Survivin Cascade Regulates the Cell Proliferation, Migration, and Tamoxifen Resistance in Breast Cancer. Front Pharmacol 2020;11:550469. [PMID: 33013387 DOI: 10.3389/fphar.2020.550469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Álvarez-León W, Mendieta I, Delgado-González E, Anguiano B, Aceves C. Molecular Iodine/Cyclophosphamide Synergism on Chemoresistant Neuroblastoma Models. Int J Mol Sci 2021;22:8936. [PMID: 34445656 DOI: 10.3390/ijms22168936] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Veiga GLD, Silva RDMD, Pereira EC, Azzalis LA, Alves BDCA, Gehrke FDS, Gascón TM, Fonseca FLA. The role of Survivin as a biomarker and potential prognostic factor for breast cancer. Rev Assoc Med Bras 2019;65:893-901. [DOI: 10.1590/1806-9282.65.6.893] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
73 Liu K, Xue B, Bai G, Zhang W. Downregulation of Diacylglycerol kinase zeta (DGKZ) suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest. Bioengineered 2021;12:1517-29. [PMID: 33926342 DOI: 10.1080/21655979.2021.1918505] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
74 Wang X, Zhang X, Qiu C, Yang N. STAT3 Contributes to Radioresistance in Cancer. Front Oncol 2020;10:1120. [PMID: 32733808 DOI: 10.3389/fonc.2020.01120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
75 Bouchet BP, Akhmanova A, Ewald A. Microtubules in 3D cell motility. Journal of Cell Science 2017;130:39-50. [DOI: 10.1242/jcs.189431] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 14.8] [Reference Citation Analysis]
76 Lee J, Park J, Lee H, Jang S, Ryu S, Kim H, Kim D, Jang A, Yang S. l-carnosine induces apoptosis/cell cycle arrest via suppression of NF-κB/STAT1 pathway in HCT116 colorectal cancer cells. In Vitro Cell Dev Biol -Animal 2018;54:505-12. [DOI: 10.1007/s11626-018-0264-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
77 Sethunath V, Hu H, De Angelis C, Veeraraghavan J, Qin L, Wang N, Simon LM, Wang T, Fu X, Nardone A, Pereira R, Nanda S, Griffith OL, Tsimelzon A, Shaw C, Chamness GC, Reis-Filho JS, Weigelt B, Heiser LM, Hilsenbeck SG, Huang S, Rimawi MF, Gray JW, Osborne CK, Schiff R. Targeting the Mevalonate Pathway to Overcome Acquired Anti-HER2 Treatment Resistance in Breast Cancer. Mol Cancer Res 2019;17:2318-30. [PMID: 31420371 DOI: 10.1158/1541-7786.MCR-19-0756] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
78 Miyamoto R, Kurita S, Tani H, Ikeda T, Ishizaka M, Saima H, Kobayashi M, Tamura K, Bonkobara M. Canine squamous cell carcinoma cell lines with high expression of survivin are sensitive to survivin inhibitor YM155. The Veterinary Journal 2018;240:31-6. [DOI: 10.1016/j.tvjl.2018.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
79 Hardiany NS, Yo EC, Ngadiono E, Wanandi SI. Gene Expression of Molecules Regulating Apoptotic Pathways in Glioblastoma Multiforme Treated with Umbilical Cord Stem Cell Conditioned Medium. Malays J Med Sci 2019;26:35-45. [PMID: 31908585 DOI: 10.21315/mjms2019.26.6.4] [Reference Citation Analysis]
80 Chen H, Fan X, Zhao Y, Zhi D, Cui S, Zhang E, Lan H, Du J, Zhang Z, Zhang S, Zhen Y. Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor. ACS Appl Mater Interfaces 2020;12:22074-87. [PMID: 32083833 DOI: 10.1021/acsami.9b22440] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
81 Bi Z, Liu W, Ding R, Wu Y, Dou R, Zhang W, Yuan X, Liu X, Xiong L, Guo Z, Mao C. A novel peptide, 9R-P201, strongly inhibits the viability, proliferation and migration of liver cancer HepG2 cells and induces apoptosis by down-regulation of FoxM1 expression. Eur J Pharmacol 2017;796:175-89. [PMID: 28012972 DOI: 10.1016/j.ejphar.2016.12.029] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
82 Badr G, El-reda GA, El-gamal H, Farid ME. Exposure to radioactive rocks from the Egyptian eastern desert attenuates the efficiency of the immune organs and induces apoptosis of blood lymphocytes in rat model. Environ Sci Pollut Res 2020;27:8684-95. [DOI: 10.1007/s11356-019-07572-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
83 Garrido MP, Hurtado I, Valenzuela-Valderrama M, Salvatierra R, Hernández A, Vega M, Selman A, Quest AFG, Romero C. NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE2 Signaling Axis. Cancers (Basel) 2019;11:E1970. [PMID: 31817839 DOI: 10.3390/cancers11121970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
84 Sonehara NM, Lacerda JZ, Jardim-Perassi BV, de Paula Jr R Jr, Moschetta-Pinheiro MG, Souza YST, de Andrade JCJ, De Campos Zuccari DAP. Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines. Oncol Lett 2019;17:1635-45. [PMID: 30675223 DOI: 10.3892/ol.2018.9758] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
85 Zafari P, Rafiei A, Esmaeili S, Moonesi M, Taghadosi M. Survivin a pivotal antiapoptotic protein in rheumatoid arthritis. J Cell Physiol 2019;234:21575-87. [DOI: 10.1002/jcp.28784] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
86 Serafino A, Sferrazza G, Colini Baldeschi A, Nicotera G, Andreola F, Pittaluga E, Pierimarchi P. Developing drugs that target the Wnt pathway: recent approaches in cancer and neurodegenerative diseases. Expert Opin Drug Discov 2017;12:169-86. [PMID: 27960558 DOI: 10.1080/17460441.2017.1271321] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
87 Mak CS, Yung MM, Hui LM, Leung LL, Liang R, Chen K, Liu SS, Qin Y, Leung TH, Lee KF, Chan KK, Ngan HY, Chan DW. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis. Mol Cancer 2017;16:11. [PMID: 28095864 DOI: 10.1186/s12943-017-0582-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 62] [Article Influence: 12.5] [Reference Citation Analysis]
88 Li KL, Wang YF, Qin JR, Wang F, Yang YT, Zheng LW, Li MH, Kong J, Zhang W, Yang HY. Rapamycin enhances the anti-angiogenesis and anti-proliferation ability of YM155 in oral squamous cell carcinoma. Tumour Biol 2017;39:1010428317706213. [PMID: 28618939 DOI: 10.1177/1010428317706213] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
89 Rosner A, Kravchenko O, Rinkevich B. IAP genes partake weighty roles in the astogeny and whole body regeneration in the colonial urochordate Botryllus schlosseri. Dev Biol 2019;448:320-41. [PMID: 30385275 DOI: 10.1016/j.ydbio.2018.10.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
90 Pluthero FG, Kahr WHA. The Birth and Death of Platelets in Health and Disease. Physiology (Bethesda) 2018;33:225-34. [PMID: 29638183 DOI: 10.1152/physiol.00005.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
91 Zhi Y, Wu X, Shen W, Wang Y, Zhou X, He P, Pan J, Chen Z, Li W, Zhou Z. Synthesis and pharmacological evaluation of novel epidermal growth factor receptor inhibitors against prostate tumor cells. Oncol Lett 2018;16:6522-30. [PMID: 30405791 DOI: 10.3892/ol.2018.9438] [Reference Citation Analysis]
92 Lorenzetti MA, Mosna MJ, De Matteo EN, García Lombardi M, Colli SL, Preciado MV. Overexpression of survivin in pediatric Hodgkin lymphoma tumor cells: Characterization of protein expression and splice-variants transcription profile. Exp Mol Pathol 2019;108:24-31. [PMID: 30876863 DOI: 10.1016/j.yexmp.2019.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Geng J, Lei YR, Pei SG. Correlation between Survivin expression and laryngeal carcinoma: A meta-analysis. J Huazhong Univ Sci Technolog Med Sci 2017;37:965-73. [PMID: 29270761 DOI: 10.1007/s11596-017-1835-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Xiao M, Xue Y, Wu Z, Lei ZN, Wang J, Chen ZS, Li W. Design, synthesis and biological evaluation of selective survivin inhibitors. J Biomed Res 2019;33:82-100. [PMID: 30174320 DOI: 10.7555/JBR.31.20160173] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 El-Ashmawy NE, El-Zamarany EA, Khedr NF, Selim HM, Khedr EG. Inhibition of PKC/MEK pathway suppresses β1-integrin and mitigates breast cancer cells proliferation. Toxicol Rep 2021;8:1530-7. [PMID: 34408972 DOI: 10.1016/j.toxrep.2021.07.012] [Reference Citation Analysis]
96 Lee EY, Gong E, Shin J, Moon J, Shim HJ, Kim S, Lee S, Jeong J, Gong JH, Kim MJ, Lee DH, Park YS, Shin J, Hong S, Kim YS, Jin D. Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin. Toxicology in Vitro 2018;46:229-36. [DOI: 10.1016/j.tiv.2017.09.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
97 Soliman NA, Abo El Gheit RE, Abdel Ghafar MT, AbuoHashish NA, Ibrahim MAA, Abo Safia HS, El-Saka MH, Elshamy AM. Unraveling the biomechanistic role of Rac1/TWEAK/Fn14/NF-κB intricate network in experimentally doxorubicin-induced cardiotoxicity in rats: The role of curcumin. J Biochem Mol Toxicol 2021;35:e22829. [PMID: 34047412 DOI: 10.1002/jbt.22829] [Reference Citation Analysis]
98 Sari C, SÜmer C, Celep EyÜpoĞlu F. Caffeic acid phenethyl ester induces apoptosis in colorectal cancer cells via inhibition of survivin. Turk J Biol 2020;44:264-74. [PMID: 33110364 DOI: 10.3906/biy-2003-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
99 Do M, Kwak IH, Ahn JH, Lee IJ, Lee JH. Survivin protects fused cancer cells from cell death. BMB Rep 2017;50:361-6. [PMID: 28193315 DOI: 10.5483/bmbrep.2017.50.7.185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Yan X, Li P, Zhan Y, Qi M, Liu J, An Z, Yang W, Xiao H, Wu H, Qi Y, Shao H. Dihydroartemisinin suppresses STAT3 signaling and Mcl-1 and Survivin expression to potentiate ABT-263-induced apoptosis in Non-small Cell Lung Cancer cells harboring EGFR or RAS mutation. Biochem Pharmacol 2018;150:72-85. [PMID: 29360439 DOI: 10.1016/j.bcp.2018.01.031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
101 Xu H, Liang T, Yang Y, Dong Y, Zhu L. Antisense of survivin inhibits cervical cancer growth in mice. Arch Med Sci 2019;15:1345-51. [PMID: 31572483 DOI: 10.5114/aoms.2017.71069] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
102 Maioral MF, Stefanes NM, Bigolin Á, Zatelli GA, Philippus AC, de Barcellos Falkenberg M, Santos-Silva MC. MICONIDINE acetate, a new selective and cytotoxic compound with synergic potential, induces cell cycle arrest and apoptosis in leukemia cells. Invest New Drugs 2019;37:912-22. [PMID: 30569243 DOI: 10.1007/s10637-018-0694-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
103 Pengnam S, Plianwong S, Patrojanasophon P, Radchatawedchakoon W, Yingyongnarongkul BE, Opanasopit P, Charoensuksai P. Synergistic Effect of Doxorubicin and siRNA-Mediated Silencing of Mcl-1 Using Cationic Niosomes against 3D MCF-7 Spheroids. Pharmaceutics 2021;13:550. [PMID: 33919902 DOI: 10.3390/pharmaceutics13040550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Santarelli A, Mascitti M, Lo Russo L, Sartini D, Troiano G, Emanuelli M, Lo Muzio L. Survivin-Based Treatment Strategies for Squamous Cell Carcinoma. Int J Mol Sci 2018;19:E971. [PMID: 29587347 DOI: 10.3390/ijms19040971] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
105 Martínez-García D, Pérez-Hernández M, Korrodi-Gregório L, Quesada R, Ramos R, Baixeras N, Pérez-Tomás R, Soto-Cerrato V. The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models. Biomolecules 2019;9:E361. [PMID: 31412593 DOI: 10.3390/biom9080361] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
106 Fiedler M, Weber F, Hautmann MG, Haubner F, Reichert TE, Klingelhöffer C, Schreml S, Meier JK, Hartmann A, Ettl T. Biological predictors of radiosensitivity in head and neck squamous cell carcinoma. Clin Oral Investig 2018;22:189-200. [PMID: 28315964 DOI: 10.1007/s00784-017-2099-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
107 Zhou L, Lu J, Liang ZY, Zhou WX, Yuan D, Li BQ, You L, Guo JC, Zhao YP. High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma. J Surg Oncol 2018;118:1115-21. [PMID: 30261114 DOI: 10.1002/jso.25253] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
108 Stegantseva MV, Shinkevich VA, Tumar EM, Meleshko AN. Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model. Cancer Immunol Immunother 2020;69:2613-22. [PMID: 32594197 DOI: 10.1007/s00262-020-02652-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
109 Morsy MA, Khalaf HM, Rifaai RA, Bayoumi AMA, Khalifa EMMA, Ibrahim YF. Canagliflozin, an SGLT-2 inhibitor, ameliorates acetic acid-induced colitis in rats through targeting glucose metabolism and inhibiting NOX2. Biomed Pharmacother 2021;141:111902. [PMID: 34328119 DOI: 10.1016/j.biopha.2021.111902] [Reference Citation Analysis]
110 Okumu DO, East MP, Levine M, Herring LE, Zhang R, Gilbert TSK, Litchfield DW, Zhang Y, Graves LM. BIRC6 mediates imatinib resistance independently of Mcl-1. PLoS One 2017;12:e0177871. [PMID: 28520795 DOI: 10.1371/journal.pone.0177871] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
111 Mazur J, Roy K, Kanwar JR. Recent advances in nanomedicine and survivin targeting in brain cancers. Nanomedicine (Lond) 2018;13:105-37. [PMID: 29161215 DOI: 10.2217/nnm-2017-0286] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 5.8] [Reference Citation Analysis]
112 Huang Q, Li S, Zhang L, Qiao X, Zhang Y, Zhao X, Xiao G, Li Z. CAPE-pNO2 Inhibited the Growth and Metastasis of Triple-Negative Breast Cancer via the EGFR/STAT3/Akt/E-Cadherin Signaling Pathway. Front Oncol 2019;9:461. [PMID: 31214503 DOI: 10.3389/fonc.2019.00461] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
113 Zhang S, Jiang VC, Han G, Hao D, Lian J, Liu Y, Zhang R, McIntosh J, Wang R, Dang M, Dai E, Wang Y, Santos D, Badillo M, Leeming A, Chen Z, Hartig K, Bigcal J, Zhou J, Kanagal-Shamanna R, Ok CY, Lee H, Steiner RE, Zhang J, Song X, Nair R, Ahmed S, Rodriquez A, Thirumurthi S, Jain P, Wagner-Bartak N, Hill H, Nomie K, Flowers C, Futreal A, Wang L, Wang M. Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma. Nat Commun 2021;12:2877. [PMID: 34001881 DOI: 10.1038/s41467-021-22872-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
114 Yan S, Dey P, Ziegler Y, Jiao X, Kim SH, Katzenellenbogen JA, Katzenellenbogen BS. Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer. Breast Cancer Res Treat 2021;185:281-92. [PMID: 33001337 DOI: 10.1007/s10549-020-05948-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
115 Zhou J, Chng WJ. Aberrant RNA splicing and mutations in spliceosome complex in acute myeloid leukemia. Stem Cell Investig 2017;4:6. [PMID: 28217708 DOI: 10.21037/sci.2017.01.06] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
116 ElMokh O, Ruffieux-Daidié D, Roelli MA, Stooss A, Phillips WA, Gertsch J, Dettmer MS, Charles RP. Combined MEK and Pi3'-kinase inhibition reveals synergy in targeting thyroid cancer in vitro and in vivo. Oncotarget 2017;8:24604-20. [PMID: 28445948 DOI: 10.18632/oncotarget.15599] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
117 Erdogan S, Turkekul K, Dibirdik I, Doganlar ZB, Doganlar O, Bilir A. Midkine silencing enhances the anti–prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB. Invest New Drugs 2020;38:246-63. [DOI: 10.1007/s10637-019-00774-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
118 Zhang Y, Sun Y, Jia Y, Zhang Q, Zhu P, Ma X. α5-nAChR and survivin: Two potential biological targets in lung adenocarcinoma. J Cell Physiol 2021;236:1787-97. [PMID: 33196129 DOI: 10.1002/jcp.29956] [Reference Citation Analysis]
119 Syahrani RA, Yunita E, Wanandi SI. Suppression of Rotenone-Treated Human Breast Cancer Stem Cell Survival Using Survivin Inhibitor YM155 is Associated to Oxidative Stress Modulation. Asian Pac J Cancer Prev 2020;21:2631-7. [PMID: 32986362 DOI: 10.31557/APJCP.2020.21.9.2631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Tsuneki M, Kinjo T, Mori T, Yoshida A, Kuyama K, Ohira A, Miyagi T, Takahashi K, Kawai A, Chuman H, Yamazaki N, Masuzawa M, Arakawa H. Survivin: A novel marker and potential therapeutic target for human angiosarcoma. Cancer Sci 2017;108:2295-305. [PMID: 28845553 DOI: 10.1111/cas.13379] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
121 Noubissi FK, Yedjou CG, Spiegelman VS, Tchounwou PB. Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma. Int J Environ Res Public Health 2018;15:E1442. [PMID: 29987229 DOI: 10.3390/ijerph15071442] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
122 Kang K, Xie F, Mao J, Bai Y, Wang X. Significance of Tumor Mutation Burden in Immune Infiltration and Prognosis in Cutaneous Melanoma. Front Oncol 2020;10:573141. [PMID: 33072607 DOI: 10.3389/fonc.2020.573141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
123 Wang L, Dai G, Yang J, Wu W, Zhang W. Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by y-Secretase Inhibitor RO4929097. Med Sci Monit 2018;24:4046-53. [PMID: 29899322 DOI: 10.12659/MSM.909452] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
124 Catalani E, Proietti Serafini F, Zecchini S, Picchietti S, Fausto AM, Marcantoni E, Buonanno F, Ortenzi C, Perrotta C, Cervia D. Natural products from aquatic eukaryotic microorganisms for cancer therapy: Perspectives on anti-tumour properties of ciliate bioactive molecules. Pharmacol Res 2016;113:409-20. [PMID: 27650755 DOI: 10.1016/j.phrs.2016.09.018] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
125 Weidle UH, Birzele F, Kollmorgen G, Nopora A. Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis. Cancer Genomics Proteomics 2018;15:1-15. [PMID: 29275359 DOI: 10.21873/cgp.20061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 21] [Article Influence: 0.7] [Reference Citation Analysis]
126 Luo C, Yuan R, Chen L, Zhou W, Shen W, Qiu Y, Shao J, Yan J, Shao J. TAB3 upregulates Survivin expression to promote colorectal cancer invasion and metastasis by binding to the TAK1-TRAF6 complex. Oncotarget 2017;8:106565-76. [PMID: 29290971 DOI: 10.18632/oncotarget.22497] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
127 Mokhlesi A, Talkhabi M. Comprehensive transcriptomic analysis identifies novel regulators of lung adenocarcinoma. J Cell Commun Signal 2020;14:453-65. [PMID: 32415511 DOI: 10.1007/s12079-020-00565-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
128 Lohberger B, Glaenzer D, Eck N, Steinecker-Frohnwieser B, Leithner A, Rinner B, Kerschbaum-Gruber S, Georg D. Effects of a combined therapy of bortezomib and ionizing radiation on chondrosarcoma three-dimensional spheroid cultures. Oncol Lett 2021;21:428. [PMID: 33868466 DOI: 10.3892/ol.2021.12689] [Reference Citation Analysis]
129 Han L, Yuan B, Shimada R, Hayashi H, Si N, Zhao HY, Bian B, Takagi N. Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87. Int J Oncol 2018;53:2488-502. [PMID: 30272276 DOI: 10.3892/ijo.2018.4567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
130 Manimaran A, Buddhan R, Manoharan S. EMODIN DOWNREGULATES CELL PROLIFERATION MARKERS DURING DMBA INDUCED ORAL CARCINOGENESIS IN GOLDEN SYRIAN HAMSTERS. Afr J Tradit Complement Altern Med 2017;14:83-91. [PMID: 28573225 DOI: 10.21010/ajtcam.v14i2.10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
131 Li Q, Li H, Zhao X, Wang B, Zhang L, Zhang C, Zhang F. DNA Methylation Mediated Downregulation of miR-449c Controls Osteosarcoma Cell Cycle Progression by Directly Targeting Oncogene c-Myc. Int J Biol Sci 2017;13:1038-50. [PMID: 28924385 DOI: 10.7150/ijbs.19476] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
132 Aceves C, Mendieta I, Anguiano B, Delgado-González E. Molecular Iodine Has Extrathyroidal Effects as an Antioxidant, Differentiator, and Immunomodulator. Int J Mol Sci 2021;22:1228. [PMID: 33513754 DOI: 10.3390/ijms22031228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
133 Wu CC, Chiang CY, Liu SJ, Chen HW. A Novel Recombinant Fcγ Receptor-Targeted Survivin Combines with Chemotherapy for Efficient Cancer Treatment. Biomedicines 2021;9:806. [PMID: 34356870 DOI: 10.3390/biomedicines9070806] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Tampa M, Caruntu C, Mitran M, Mitran C, Sarbu I, Rusu LC, Matei C, Constantin C, Neagu M, Georgescu SR. Markers of Oral Lichen Planus Malignant Transformation. Dis Markers 2018;2018:1959506. [PMID: 29682099 DOI: 10.1155/2018/1959506] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
135 Fan L, Tian M, Liu Y, Deng Y, Liao Z, Xu J. Salicylate •Phenanthroline copper (II) complex induces apoptosis in triple-negative breast cancer cells. Oncotarget 2017;8:29823-32. [PMID: 28415735 DOI: 10.18632/oncotarget.16161] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
136 Castro-Gamero AM, Pezuk JA, Brassesco MS, Tone LG. G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future. Cancer Biol Med 2018;15:354-74. [PMID: 30766748 DOI: 10.20892/j.issn.2095-3941.2018.0030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
137 Zhang Y, Lu P, Du H, Zhang L. LINK-A lncRNA Promotes Proliferation and Inhibits Apoptosis of Mantle Cell Lymphoma Cell by Upregulating Survivin. Med Sci Monit 2019;25:365-70. [PMID: 30636001 DOI: 10.12659/MSM.912141] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]